Axogen, Inc. Common Stock (AXGN) is a publicly traded Healthcare sector company. As of October 23, 2026, AXGN trades at $35.26 with a market cap of $2.14B and a P/E ratio of -61.02. AXGN moved -3.87% today. Year to date, AXGN is +15.49%; over the trailing twelve months it is +103.21%. Its 52-week range spans $9.22 to $52.91. Analyst consensus is strong buy with an average price target of $53.67. Rallies surfaces AXGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AXGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AXGN recently traded at $35.26. Market cap is $2.14B. P/E ratio is -61.02. Revenue is $251.17M.
| Metric | Value |
|---|---|
| Price | $35.26 |
| Market Cap | $2.14B |
| P/E Ratio | -61.02 |
| EPS | $-0.67 |
| Dividend Yield | 1.00% |
| 52-Week High | $52.91 |
| 52-Week Low | $9.22 |
| Volume | 241 |
| Avg Volume | 0 |
| Revenue (TTM) | $251.17M |
| Net Income | $-33.55M |
| Gross Margin | 74.56% |
12 analysts cover AXGN: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $53.67.